Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Extension Trial of Repeated Infusions of ISF35
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
- Status
- COMPLETED
- Phase
- PHASE1
Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL
- Status
- COMPLETED
- Phase
- PHASE1
Alemtuzumab + Rituximab Consolidation in CLL
- Status
- TERMINATED
- Phase
- PHASE2
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
- Status
- COMPLETED
- Phase
- PHASE1
Assess the Oral Bioavailability of New ABT-263 Formulations
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
8-Chloro-Adenosine in Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
- Status
- COMPLETED
- Phase
- PHASE2
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
- Status
- COMPLETED
- Phase
- PHASE1